EULAR Rheumatology Open
Издатель: Elsevier · ISSN 3050-7081 · 79 статей
- A systematic literature review to inform the 2025 EULAR recommendations for the management of polymyalgia rheumatica and primary large vessel vasculitis: management of disease including relapse and complications
- Arrhythmic risk in axial spondyloarthritis: a narrative review
- Does articular and entheseal structural damage drive pain and patient-driven reported outcomes in patients with difficult-to-treat psoriatic arthritis? Results from a cross-sectional study
- Mechanisms of fibrosis and novel antifibrotic therapies
- From drug mechanism–based to driver-guided therapy: targeting disease drivers in psoriatic arthritis
- From pixels to prediction: improving imaging through AI in rheumatology
- 3D printing in rheumatology
- Early experience of avacopan for ANCA-associated vasculitis in an Australian paediatric population: a case series
- Dual somatic UBA1 Met41 variants with distinct allele frequencies in VEXAS syndrome
- Benralizumab response in adult-onset Still’s disease with eosinophilic complications and associated lung disease: DRESS or biologics-induced cytokine imbalance?
- Assessment of EAPSDAS in critically ill patients with antiphospholipid syndrome
- Obinutuzumab exposure during early twin pregnancy in antisynthetase syndrome with interstitial lung disease
- Anti-inflammatory approaches in cancer immunotherapy-induced autoimmunity
- CAR-T cells and CAR-Treg cells for treatment of inflammatory bowel diseases
- When inflammation is not the driver: Pauci-immune synovitis and the stromal basis of refractory arthritis
- Immunomodulatory metabolites in rheumatic diseases
- Extra-articular rheumatoid arthritis: example of RA-associated interstitial lung disease
- EULAR Rheumatology Open Special Issue titled ‘VSI: ATT2026’: the role of clonal haematopoiesis in immunological and rheumatological diseases
- New treatments in myositis on the horizon
- Prevention of rheumatoid arthritis: state-of-the-art and considerations for the design of new trials
- Individual patient disease activity expression profiles modify the relation between disease activity and structural damage progression in RA
- Multifactorial lifestyle interventions in rheumatoid arthritis: a systematic literature review
- Sustained pain improvement and IL-12-related biomarker changes in rheumatoid arthritis patients initiating baricitinib or TNF inhibitor therapy
- Deletion of a rheumatoid arthritis risk enhancer in mouse disrupts Bim expression and immune homeostasis
- Fish consumption, omega-3 fatty acids, and risk of developing rheumatoid arthritis: a systematic review and meta-analysis
- Association between patient characteristics, demographics, and social determinants of health with treatment-refractory and complex-to-manage psoriatic arthritis
- Sex-specific outcomes in methotrexate therapy among patients with psoriatic arthritis and psoriasis
- Disease activity, treatment use, and patient-reported burden in systemic lupus erythematosus (SLE): the real-world multicentre NYMERIA study
- Selection of relevant domains and instruments for the ASAS core set to assess axial spondyloarthritis in clinical practice: a Delphi survey of stakeholders
- MRI-assessed structural damage progression in sacroiliac joints of European routine care patients with axial spondyloarthritis receiving biological or conventional therapy